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Abstract
Background: Throughout sub-Saharan Africa HIV-testing rates remain low. Barriers to testing, such as inconvenient
service hours and long wait times, lack of privacy, and fear of unwanted disclosure, continue to impede service
utilization. HIV self-testing (HIVST) is one strategy that addresses these barriers and has been shown to increase use
of HIV-testing when distributed through community-based settings. However, the scalability of HIVST is limited
because it has yet to be fully integrated into existing health systems and routine care. To address this gap, we
designed a study to test the effect of offering HIVST to routine outpatient department (OPD) clients on uptake of
HIV-testing as compared to standard of care and optimized standard of care.
Methods/design: This is a non-blinded, multi-site, cluster-randomized control trial. The health facility is the unit of
randomization (cluster). Fifteen facilities were randomized to one of three arms: (1) Standard of care using routine
provider-initiated testing and counseling (PITC); (2) Optimized standard of care using optimized PITC defined by
additional training, job aids, and monitoring of PITC strategies with OPD providers and support staff; and (3) HIVST
defined by HIVST demonstrations for OPD clients, HIVST kit distribution, and private spaces for HIVST kit use and/or
interpretation. The primary outcome is the proportion of OPD clients tested for HIV on the day that they accessed
OPD services. Secondary outcome measures are the proportion of OPD clients newly identified as HIV-positive and
antiretroviral therapy (ART) initiation. Costs and cost-effectiveness will be evaluated. Nested studies will determine
the acceptability of facility-based HIVST among OPD clients and health care providers, the presence of adverse
events, such as coercion to test or unwanted status disclosure, and a process evaluation to determine feasibility and
scale-up of facility-based HIVST for the future.
Discussion: This study protocol tests whether facility-based HIVST can positively contribute to HIV-testing among
OPD clients in resource-limited settings. This will be one of the first studies to test the integration of HIVST into
facility-based, primary health services in sub-Saharan Africa.
Trial registration: ClinicalTrials.gov, ID: NCT03271307. Registered on 31 August 2017.
Pan African Clinical Trials: PACTR201711002697316. Registered on 1 November 2017.
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Background
Despite increased access to human immunodeficiency
virus (HIV)-testing in sub-Saharan Africa, only 45% of
HIV-positive individuals know their status [1]. Barriers
to testing include limited access to testing services, long
wait times, lack of privacy, and fear of unwanted disclos-
ure and stigma [2, 3]. Low use of HIV-testing has signifi-
cant implications for the 90–90–90 UNAIDS goals that
aim for 90% of individuals to know their HIV status, a
critical target for curbing the epidemic by 2020 [4]. In
order for the first 90 to be reached, new innovations are
needed to increase testing.
HIV self-testing (HIVST) is one strategy to increase
testing. Self-testing in sub-Saharan Africa is highly ac-
ceptable, accurate, and safe [5–8]. When distributed
through community-based strategies, self-testing signifi-
cantly increases the use of testing among hard-to-reach
populations such as men and adolescents [6]. However,
to date, HIVST strategies have been largely removed
from existing health care systems, relying primarily on
community-based distribution strategies [5, 6, 9, 10]. Poor
integration into national health systems limits the reach
and scalability of HIVST, particularly in low-resource set-
tings where Ministries of Health (MOHs) are already
strained and have limited capacity for community-based
interventions. In addition, linkage to care for those who
test HIV-positive through community-based HIVST re-
mains a challenge [11–14]. Strategies to integrate HIVST
within existing health systems are needed.
Recent studies have begun integrating HIVST into
health systems by using female clients to distribute HIVST
kits to male partners in their home [15, 16]. However, this
strategy does not address the challenge of linkage to care.
It also increases the burden of care for women who are
already made largely responsible for the health of their
family and uptake of health services [17, 18]. The above
limitations may be mitigated by distributing HIVST dir-
ectly to the intended users at health facilities. Distribution
and use of HIVST alongside other facility-based services
may improve the scalability of HIVST as well as linkage to
antiretroviral therapy (ART) services. Additionally, the use
of HIVST in facilities can increase the number of tests
performed among facility clients and reduce the burden of
testing for facility staff because HIVST does not require
direct supervision by a health care worker. In summary,
HIVST in facilities may be a strategy to test more people
with increased efficiency and decreased costs compared to
standard provider-initiated testing and counseling (PITC).
A review of the literature shows that no previous random-
ized control trial (RCT) has been conducted on the distri-
bution and use of HIVST within existing health facilities.
This protocol outlines our proposed methods for a
non-blinded, cluster-randomized, matched-controlled trial
(cRCT) that tests the effectiveness of integrating HIVST
into routine outpatient services in Malawi. We will use
three randomization arms: (1) standard of care HIV blood
test offered through routine PITC among clients attending
the outpatient department (OPD); (2) HIV blood test
offered through optimized PITC among OPD clients; and
(3) HIVST offered to OPD clients while waiting for rou-
tine services (intervention). By combining HIVST with
existing facility-based health services, findings may help
improve the scalability of HIVST strategies and inform
national guidelines for HIV-testing.
Methods/design
Objectives
Our overarching objective is to test the feasibility and
cost-effectiveness of HIVST among adults receiving
OPD health services in Malawi.
Primary objective
To test whether distributing HIVST at OPD compared
to standard of care and PITC will:
 Increase the proportion of OPD clients tested for
HIV
Secondary objective
To test whether distributing HIVST at OPD compared
to standard of care and PITC will:
 Be cost-effective
 Increase the proportion of OPD clients newly
identified as HIV-positive
 Increase ART initiation among HIV-positive clients
tested at OPD
To assess if HIVST at OPD is:
 Acceptable to clients and providers
 Associated with the presence of adverse events such
as coercion to test or unwanted status disclosure
Trial design
We use a non-blinded, cluster-randomized, matched-
controlled trial design. The health facility is the unit of
randomization (cluster). Fifteen health facilities were
randomized in a 1:1:1 allocation to one of three arms:
(1) Standard of care (SOC) using routine PITC; (2) Opti-
mized standard of care (OSOC) using optimized PITC
defined by additional training, job aids, and monitoring
of PITC strategies with OPD providers and support staff;
and (3) HIVST (see Fig. 1).
Trial setting and population
The study will take place in central and southern Malawi.
Malawi recently implemented universal treatment for HIV,
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whereby all clients are eligible for immediate initiation of
antiretroviral treatment (ART) [19]. In Malawi, 9% of the
adult population are living with HIV, and 42% have tested
for HIV in the past year [20]. Study sites include mid- to
large-level health facilities that offer outpatient and
HIV-testing and treatment services. Sites vary by facility
type (hospital/health center), ownership (public/mission),
location (rural/urban), and region (central/southern). All
adult clients attending OPD services at the time of the
study will be eligible for participation. Clients will be ex-
cluded if they are under 15 years of age or are not receiving
OPD services on the day of recruitment.
Randomization
Block randomization was used to minimize imbalances be-
tween arms. Clusters were blocked by facility type, owner-
ship, and region. Fifteen clusters were allocated 1:1:1 to
either the SOC, OSOC, or HIVST arm. Randomization was
done by the project statistician using a computer-generated
sequence of random numbers. Randomization outputs were
shared with the MOH, district-level governance, and med-
ical providers at participating sites in order to maximize
transparency of randomization and increase study buy-in.
Intervention
Standard of care arm
All eligible OPD clients attending facilities allocated to the
SOC arm will receive standard OPD services. Providers
will offer HIV-testing based on their own discretion, as
per national guidelines. Current MOH guidelines stipulate
that HIV-testing is performed by a certified HIV-testing
counselor with blood obtained by fingerstick using Deter-
mine 1/2™. A positive test is followed by a confirmatory
test using Uni-Gold. Pre- and post-counseling should be
provided. Pre-counseling may be provided in a group
setting while post-counseling should be provided in a
one-on-one format. Guidelines recommend that providers
offer HIV-testing to all OPD clients; however, priority is
given to clients where there is concern for or confirmation
of tuberculosis, clients with symptoms of sexually trans-
mitted infections (STIs), and clients who report high-risk
behaviors such as more than one sexual partner in the
past 12 months or unprotected sex [19]. No intervention
or additional support will be provided at SOC sites. Stand-
ard linkage procedures will be followed. All confirmed
HIV-positive clients should be documented into the ART
linkage register by the HIV-testing counselor and then the
client is escorted to the ART clinic to be initiated on ART.
Optimized standard of care arm
All eligible OPD clients attending facilities allocated to
the OSOC arm will receive standard OPD services.
Study personnel will participate in focused efforts to
support provider implementation of PITC among OPD
clients. Efforts will include PITC refresher trainings, new
strategies for PITC implementation to be developed with
providers at specific OSOC sites, and intensified moni-
toring and evaluation of PITC efforts. Standard linkage
procedures will be followed as described above.
Intervention arm
Clients will receive health education and demonstrations
on HIVST while waiting for routine OPD services. Group
education will include (1) information about the benefits
of testing and treatment, (2) eligibility criteria for use of
HIV self-test kits, (3) demonstration on how to use HIV
self-test kits, and (4) counseling on what to do if test
results are positive or negative. HIV self-test kits will be
distributed in OPD waiting areas to interested clients
seeking OPD services that day. Because HIVST can only
be used for study purposes in Malawi, the study team will
distribute HIVST kits, but a facility-based HIV counselor
Fig. 1 Trial design
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will be present. Clients will be encouraged to only take
a kit if they meet the following criteria: (1) are HIV-
uninfected or status unknown, (2) have not tested for
HIV in the past month, (3) are comfortable using
HIVST at the OPD, and (4) are 15 years or older. Cli-
ents can opt out from receiving an HIVST kit. Clients
may choose to use routine HIV-testing services if they
are uncomfortable with HIVST.
HIVST kits will be used in the OPD waiting area, and
private spaces will be available for interpreting results.
Clients will be encouraged to use and interpret the kit
before receiving standard OPD services so they can dis-
cuss the test result with their health care provider, if
desired. Clients will be asked to return anonymized used
or unused HIVST kits to the study team before leaving
the OPD so that the study can track distribution, use,
and test results.
A trained HIV counselor will be available in the
OPD waiting area to answer any questions that arise
about how to use the HIVST kit and provide immedi-
ate counseling to clients who request additional sup-
port. Status disclosure is completely optional. Clients
who disclose a positive test result to either health care
providers or study staff will be referred to undergo
confirmatory testing, using standard HIV-testing
services available at the facility. Standard linkage pro-
cedures will be followed as described above. See
Table 1 for a description of intervention components
across arms.
Study outcomes
The primary study outcome is the proportion of OPD
clients tested for HIV in each study arm. We define
tested for HIV as using either standard blood tests or
HIVST on the day that the clients receive OPD ser-
vices. The outcome will be measured through partici-
pant self-report during an exit survey and confirmed
using routine register data. In the HIVST arm, we will
also verify testing data by reviewing results of returned
HIVST kits.
Secondary outcomes include:
 Cost-effectiveness of HIVST compared to SOC and
OSOC, comparing the average cost per test
completed and the cost per HIV-positive individual
identified between the arms
 Proportion of OPD clients newly identified as
HIV-positive using self-report and register data
 The proportion of HIV-positive individuals who link
to ART services using self-report and register data
 Client acceptability of the testing strategy using
Likert scale questions
 Self-reported adverse events during service
utilization (coercion, unwanted disclosure) using
Likert scale questions, in-depth interviews, and
direct observation
Sample size considerations
We estimated our sample size assuming a fixed number
of clusters (k) and an equal number of clusters per arm
(k = 5). We assumed an equal number of participants
per cluster (n = 400) for a total sample size of 2000 par-
ticipants per arm (6000 total). Assuming an overall type
I error of 0.05, an intracluster correlation of 0.004, we
would expect at least 90% power to detect differences in
HIV-testing of 5% in the SOC arm, 10% in the OSOC
arm, and 20% in the HIVST arm. This calculation uses
the Bonferroni correction to account for multiple com-
parisons. For secondary outcomes of acceptability based
on Likert scale questions, the trial will have 80% power
to detect a minimum detectable difference of 0.165 in
effect size between any two arms.
Data collection
Across study arms, data will be collected in two ways: (1)
through a one-time exit survey with clients and (2)
through digitized routine clinic data, including OPD, ART,
and STI registers. Due to clinic workload and clinic flow, it
will be impossible to survey all OPD clients (MacPherson
2014). A maximum of 40 clients will be randomly recruited
from each facility every day to participate in an exit survey.
Recruitment, screening, oral consent, and enrolment for
exit surveys will be conducted at the health facility imme-
diately following routine OPD services. Any clients who
report testing HIV-positive that same day, or intending to
be tested for HIV that same day, will complete a written
consent and personal identifiers will be collected. Identi-
fiers will be linked to routine clinical data at the health
facility and used to assess ART initiation (for those who
tested HIV-positive) and actual use of HIV-testing (for
those who wanted to test that same day).
Table 1 Intervention components by randomization arm
Randomization arm Components
Standard of care ● Routine provider-initiated testing and
counseling
● No additional support provided
Optimized standard
of care
● Optimized provider-initiated testing and
counseling
○ Refresher trainings
○ New strategies for PITC implementation
○ Intensified monitoring and evaluation
HIVST intervention ● HIV self-testing
○ Health education and demonstration
on HIVST in the OPD waiting area
○ Distribution of HIVST in the OPD
waiting area
○ Private spaces at the OPD for reading
test results
Legend: HIVST HIV self-testing, OPD outpatient department, PITC provider-
initiated testing and counseling
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The exit survey was designed in English and translated
into Chichewa, the local language. Back translation was
completed by an independent person to check and verify
question meanings. Exit surveys will be conducted by
trained research assistants and answers recorded using
Samsung tablets. The survey was programmed using Sur-
veyCTO software (http://www.surveycto.com). Domains
in the survey include: sociodemographic; previous use of
HIV services; risk behaviour; services received at the facil-
ity that day, including HIV-testing; acceptability of the
testing strategy implemented in that arm, and for those
tested HIV-positive, plans for ART linkage. We will also
ask if the participant was offered HIV-testing that day
(either standard testing or HIVST) in order to assess the
reach of testing across all arms. Participants who
self-report as newly HIV-positive and those who did
not test but plan to test later that same day will
complete written consent, and personal identifiers will
be obtained. Identifiers will be used to assess linkage
to care for those who test positive and to determine if
those indicating they will test later actually complete a
test. Newly diagnosed HIV-positive participants who
are not linked to care within 2 months will be traced,
and outcomes will be determined (moved, died, initi-
ated at another facility, refused to initiate).
For the HIVST arm, all HIV self-test kits will be
pre-labeled with unique, anonymous participant ID num-
bers. Clients will be asked to place all used and unused
self-test kits into an anonymous locked box outside the
OPD consultation room immediately following the com-
pletion of health services. However, clients who participate
in an exit survey will return their test kit at the time of the
survey and the unique kit ID will be recorded at that time.
Survey participants who chose not to take an HIVST kit
will be given a random ID number generated by Sur-
veyCTO. Study teams will record the number of kits
distributed each day, the number of kits returned, the re-
sult of used kits, and the number of kits not returned
(missing kits).
Register data will be used to triangulate survey data
and will assess OPD attendance, proportion of OPD
clients tested for HIV, number of new HIV-positive
clients, and the proportion of HIV-positive clients
who initiate ART over the study period. Register data
will be digitized at the end of each day. See Fig. 2 for a
summary of data collection and timelines, following
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) guidelines.
Cost data
A Cost-effectiveness Analysis (CEA) design from a health
care perspective using micro-costing methods will be ap-
plied to estimate the cost of HIV-testing in all three study
arms. An HIV intervention costing instrument, developed
by the Health Economics and Epidemiology Research
Office (HE2RO) and Boston University, will be adopted to
collect costing data for the study. Resources to be cap-
tured will include: HIV-testing consumables (HIVST kits,
standard of care testing supplies), interactions with staff
(e.g., counseling, registration), staff training (for standard
of care and HIVST), and shared costs and overhead of
patient care (building space, utilities, equipment, human
resources). The sources of costing data will include
facility HIV records, procurement inventories, and
hospital personnel records. Replacement costs for all
donated equipment will be determined using either recent
procurement costs or the current market prices. Cost data
will be collected in the local currency, Malawian kwachas.
For cost information that is only available in another
currency (as with the HIVST kits), the average exchange
rate from the US dollar to the Malawian kwacha over the
previous year (at time of analysis) will be used.
HIVST kits are procured internationally, and thus
their price depends on the exchange rate and recent glo-
bal fluctuations in the price of HIVST kits. The cost of
HIVST kits will, therefore, be varied in a univariate
sensitivity analysis where all costs and outcomes remain
constant, and the price of self-tests alone is varied.
Analysis plan
Analyses will be conducted in Stata 14 (Stata Corp., College
Station, TX, USA). We will use the Consolidated Standards
of Reporting Trials (CONSORT) standards for reporting
trial outcomes [21]. We will calculate descriptive statistics,
including mean/median, variation (standard deviation, kur-
tosis), range, and frequency distributions for the demo-
graphic and clinical characteristics, overall and by study
arm. We will use intention-to-treat (ITT) principles for
primary outcome analysis. Mixed-effects models will be
used to evaluate the treatment effects on all endpoints, with
the fixed effect of treatment assignment and the random ef-
fects of study sites, to account for correlations with clusters.
This method performs well in situations where the number
of observations per cluster is large [22] and for unequal
cluster sizes [23].
We will also conduct sensitivity analyses on acceptance
of HIV-testing across arms, excluding clients who were not
offered testing or were not targeted by the intervention
(such as clients with a previous positive test result and
clients who tested HIV-negative within the past month).
Separate logistic and linear mixed-effects regression models
will be developed for each outcome of interest and will in-
clude covariates such as demographics (e.g., age, gender),
risk behavior (number of sexual partners, condom use), use
of HIV services (prior testing, prior test result), and other
structural and contextual factors. We will use multiple
imputation for imputing missing data not directly related to
primary and secondary outcomes [24].
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Secondary analyses will examine intervention effectiveness
for pre-specified sub-groups of the population, such as men
and adolescents, and will include interaction terms where
appropriate (sub-group × treatment arm) in the fixed effects.
These models will also assess the effect-modification of the
intervention effect by facility type.
Cost will be estimated using data collected through
the micro-costing strategy described above and utilizing
a cost-modeling tool developed by HE2RO and Boston
University. The incremental cost of identifying one add-
itional new positive or providing one additional test will
be calculated (the differences in costs divided by the dif-
ference in respective measure of effectiveness) between
all study arms. This incremental analysis will be further
stratified by level of health facility to see if the cost per
outcome achieved differs by facility type.
Secondary outcomes will be explored with the propor-
tions of OPD clients tested HIV-positive, and, of those
positive, linked to care. Other outcomes such as client
acceptability and potential adverse events (coercion, un-
wanted disclosure) will be explored, and only those
tested will be included in the analysis.
Nested studies
A series of nested studies will be conducted within the
HIVST arm to qualitatively assess acceptability, feasibility,
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure. *Only for the HIV self-testing (HIVST) arm
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and unintended outcomes of the facility-based HIVST
intervention.
Qualitative data with clients
A random subset of 60 participants from the HIVST
arm (30 men and 30 women) will participate in an
in-depth interview to understand client experiences with
HIVST at OPD clinics. Respondents will be stratified by
facility, sex, use of self-testing, and HIV status. Partici-
pants will be asked about their experience with HIVST
at the OPD waiting area, including concerns about
privacy, problems performing or interpreting the test,
and any perceived harms or benefits resulting from
self-testing at the OPD clinic. Participants will also be
asked about any suggestions or recommendations to im-
prove the distribution and use of HIVST kits at health
facilities. Interviews will be conducted by a trained inter-
viewer who is matched by sex with the participant (male--
male, female-female). Interviews will be digitally recorded,
transcribed, and translated into English.
Observational journals will be collected by the study
team and will be used to further understand unintended
consequences of the HIVST intervention. Observational
journals are intended to capture the content of social in-
teractions; what people say and how they interact with
one another in everyday settings, which can be quite
different from what they may say during an in-depth
interview or survey [25]. A study team member will be
assigned to observe clients in the OPD waiting area dur-
ing the HIVST intervention, taking detailed field notes.
Notes will be transcribed into journals at the end of each
day. Journals will be written in English. Similar methods
have been described elsewhere [26–29].
Interviews and observational journals will be coded
and analyzed using similar methods. An a-priori code-
book will be developed based on existing literature and
will be modified by investigators after reviewing 10 tran-
scripts. Two independent coders will code all data in
Atlas.ti using thematic analyses [30] and add new codes
as needed [31]. Discrepancies in coding and the addition
of new codes will be discussed and resolved. Final codes
will be grouped into overarching themes and reported
using verbatim quotes that represent key themes.
Focus groups with providers
Focus group discussions (FGDs) will be conducted with
health care providers in the HIVST arm to better under-
stand provider perceptions and acceptability of HIVST at
OPD clinics. Two FGDs will be conducted per facility (10
FGDs total). Focus groups will assess the perceived feasi-
bility of the intervention from a health systems perspective
and recommendations for improving the distribution and
use of HIVST kits within facilities. Discussions will pro-
vide insight into the feasibility of incorporating HIVST
into OPD clinics as part of routine care, a critical step to-
wards including facility-based HIVST strategies in national
guidelines. All FGDs will be audio-recorded, transcribed,
and translated into English. Data will be analyzed with the
same methods described above.
Implementation log sheet
We understand that an integrated HIVST intervention
at OPD clinics has not been done before, and concerns
regarding implementation are likely to occur. To track
concerns and solutions, the study team will keep a log
sheet documenting concerns, solutions, and immediate
and mid-term impact of solutions. Data sources for the
log sheet include daily reports from the study team in
the field, supervision reports, and feedback from key
stakeholders such as providers, the MOH, or clients
themselves. Findings may influence how similar inter-
ventions are implemented in the future.
Discussion
HIV self-testing offers a promising solution to reach the
first and second 90–90–90 UNAIDS goals. However,
new, innovative strategies that integrate HIVST into rou-
tine health systems are needed if the technology is to be
scaled at a national level in resource-limited settings. In
this paper, we describe the protocol of a cRCT that will
test the effectiveness of an integrated HIVST strategy
within routine OPD services in Malawi.
We differentiate our study from other HIVST studies in
several ways. First, we will promote distribution and use
of HIVST alongside other routine outpatient services.
Other studies have shown that incorporating HIV-testing
into other primary health services, such as screening for
hypertension, increases uptake [32–34]. We build on this
work by offering testing to patients accessing outpatient
health services in Malawi. Other studies have also used
health facilities as distribution points for HIVST, whereby
facility clients receive self-test kits to give to their partners
at home [15, 16]. Our study will be one of the first to
directly target the desired HIVST user and encourage test-
ing at health facilities as part of non-HIV-related health
services. Facility-based HIVST may improve linkage to
care since testers are already at the health facility, a known
limitation of other HIVST strategies [11–14].
Second, this study will be one of the first to measure
actual use of HIVST test kits as opposed to self-reported
use [6, 15, 35]. We will also be able to link HIVST re-
sults with client demographics, HIV risk, and previous
use of HIV-testing services. A study in Malawi plans to
measure HIVST usage by collecting used kits from male
partners who link to health facilities [16]; however, this
strategy will be unable to determine if unlinked partners
ever used HIVST. Based on the design of our study, we
will collect all used and unused kits as participants leave
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the health facility, allowing us to be certain of HIVST
uptake among the target population. A possible limita-
tion will be missing HIVST kits due to clients wanting
to take them home for later use or to give to a family
member or friend. However, we anticipate this will be a
small proportion of total kits distributed.
One concern with any trial testing new diagnostic
strategies is the risk of adverse events. Potential adverse
events for integrated HIVST at OPD clinics include co-
ercion to test, unwanted status disclosure, and client’s
feeling uncomfortable with the intervention, potentially
resulting in avoidance of HIV-testing and/or OPD ser-
vices in the future. Measurement of adverse events is an
important secondary outcome of the study.
The study has several limitations. The trial design may
be sensitive to the Hawthorne Effect [36]. Based on par-
ticipation in the exit survey, clients may be more aware
of the importance of HIV-testing and thus more likely to
test even after receiving all OPD services for that day,
potentially reducing the effect of the HIVST intervention
against the SOC and OSOC arms. Second, survey clients
are recruited at random and may not fully represent the
OPD client population. We will adjust for this by con-
trolling for enumerator effects. These limitations will be
noted in study findings.
The UNAIDS 90–90–90 goals are lofty targets that re-
quire new, scalable technology. HIV self-testing can con-
tribute to targets, but additional strategies to improve
HIVST scalability are needed. Our study is one of the first
to test the integration of HIVST in routine, facility-based,
primary health services. Results from the study will pro-
vide important information on facility-based HIVST strat-
egies that can be used to inform HIV-testing policies in
sub-Saharan Africa (Additional file 1).
Trial status
This manuscript was developed using study protocol
version 1.4, 16 August 2017, for aim 1 of “Use of HIV
Self-Test Kits to Increase Identification of HIV-Infected
Individuals and Their Partners.” Recruitment and enroll-
ment began on 18 September 2017. Data collection is
expected to be completed by May 2018.
Additional file
Additional file 1: Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) 2013 Checklist: recommended items to
address in a clinical trial protocol and related documents. (DOCX 52 kb)
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